시장보고서
상품코드
1327572

세계의 임균 검사 시장 규모(금액, 수량, ASP) : 부문별, 점유율, 동향, SWOT 분석, 규제와 상환 상황, 시술, 예측(-2033년)

Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

발행일: | 리서치사: GlobalData | 페이지 정보: 영문 | 배송안내 : 즉시배송


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 임균 검사 시장에 대해 조사분석했으며, 각 부문의 시장 규모, 시장 동향, 경쟁 구도, COVID-19의 영향 등의 정보를 제공하고 있습니다.

시장 모델의 주요 내용은 아래와 같습니다.

출시 임균 검사와 진화하는 경쟁 구도

  • 주요 업계 동향의 인사이트
  • 임균 검사 시장의 부문별 연간 매출과 시장 전망(2015-2033년)
  • 유닛, 평균 판매 가격, 시장 금액에 관한 시장 레벨 데이터

세계, 지역, 국가 레벨 시장 고유 인사이트

  • 세계의 동향을 지역별로 분류한 정성적인 시장 고유 정보와 국가별 인사이트
  • 임균 검사 시장의 SWOT 분석
  • 임균 검사 시장의 경쟁 역학 인사이트와 동향

의료제도의 개요를 포함한 진정한 전체상을 파악하는 것으로 시장의 이해를 촉진합니다. 또한 시장 참여 부문에서는 상환 정책 및 규제 상황에 관한 정보를 제공하고, 시장 역학을 심층 분석할 수 있습니다.

  • 국가별 의료제도의 개요
  • 국가별 상환 정책
  • 국가별 의료 기술에 관한 규제 상황

대상 기업

  • Abbott Laboratories
  • Becton Dickinson and Co
  • ZeptoMetrix Corporation
  • Danaher Corp
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Thermo Fisher Scientific Inc
  • 기타
KSA 23.08.21

Abstract

Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Neisseria Gonorrhoea Tests market for the year 2020 and beyond. Neisseria Gonorrhoea is one of the most common sexually transmitted disease (STD) worldwide, caused by the bacteria Neisseria gonorrhoea. N. gonorrhoea infections are more common in young adults. Other groups at higher risk of contracting gonorrhoea include individuals with multiple sexual partners, individuals with another STD, men who have sex with men (MSM), and sex workers. Increases in the incidence of Neisseria gonorrhoea infections are likely due in part, to a greater number of individuals being screened as well as the advent of improved screening techniques like Neisseria Gonorrhoea Nucleic Acid Amplification (NAAT) Tests, which are highly sensitive and specific.

Neisseria Gonorrhoea Tests includes Neisseria Gonorrhoea Nucleic Acid Amplification Tests (NAATs), Neisseria Gonorrhoea multiparameter CT/NG NAATs and other Neisseria Gonorrhoea tests (Direct Fluorescent Antibody (DFA), Indirect Fluorescent Antibody (IFA), Immunochromatography, Cell Culture and Point of Care devices) as sub-segments.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Neisseria Gonorrhoeae Tests and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Neisseria Gonorrhoeae Tests market revenue by segment and market outlooks from 2015- 2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Neisseria Gonorrhoeae Tests market.
  • Competitive dynamics insights and trends provided for Neisseria Gonorrhoeae Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Becton Dickinson and Co, ZeptoMetrix Corporation, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, Thermo Fisher Scientific Inc, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina. and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Neisseria Gonorrhoeae Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Neisseria Gonorrhoeae Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Neisseria Gonorrhoeae Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neisseria Gonorrhoeae Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Neisseria Gonorrhoeae Tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제